Xilio Therapeutics, Inc.
XLO
$0.71
-$0.03-4.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.39% | 62.18% | 162.13% | 23.68% | 2.49% |
| Total Receivables | -- | -- | -93.33% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 37.80% | -29.23% | -59.14% | -14.02% | -56.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 96.01% | 58.59% | 34.71% | 25.16% | -1.82% |
|
|
|||||
| Total Current Assets | 96.01% | 58.59% | 34.71% | 25.16% | -1.82% |
| Net Property, Plant & Equipment | -18.49% | -17.00% | -17.19% | -19.12% | -17.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.46% | -3.60% | -38.00% | 11.51% | 1.49% |
| Total Assets | 79.08% | 48.89% | 25.55% | 16.66% | -4.09% |
|
|
|||||
| Total Accounts Payable | 136.63% | 224.13% | 204.96% | 145.14% | -34.59% |
| Total Accrued Expenses | -8.59% | -42.27% | -51.47% | -4.92% | 4.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.11% | 12.56% | 10.55% | -73.06% | -80.92% |
| Total Finance Division Other Current Liabilities | 67.96% | 59.44% | 85.28% | -- | -- |
| Total Other Current Liabilities | 67.96% | 59.44% | 85.28% | -- | -- |
| Total Current Liabilities | 48.34% | 37.83% | 50.84% | 70.84% | 124.60% |
|
|
|||||
| Total Current Liabilities | 48.34% | 37.83% | 50.84% | 70.84% | 124.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.94% | -16.71% | -15.58% | -14.59% | -13.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 845.68% | 555.43% | 122.66% | -- | -- |
| Total Liabilities | 164.12% | 124.50% | 63.63% | 121.91% | 111.82% |
|
|
|||||
| Common Stock & APIC | 7.51% | 7.66% | 10.65% | 10.77% | 8.68% |
| Retained Earnings | -15.78% | -15.76% | -15.84% | -17.89% | -20.40% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -138.60% | -78.85% | -58.47% | -52.21% | -60.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -138.60% | -78.85% | -58.47% | -52.21% | -60.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -138.60% | -78.85% | -58.47% | -52.21% | -60.05% |
|
|
|||||